Company: SUPN
Filing Date: 2025-05-06
Form Type: 8-K
Source: 0001356576-25-000031
Chunk: 2

Company: SUPERNUS PHARMACEUTICALS, INC.
Filing Date: 2025-05-06
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item 9.01

Financial Statements and Exhibits*.

(d) Exhibits

Exhibit 99.1 - Press Release Dated May 6, 2025 furnished as an Exhibit pursuant to Item 2.02 hereof.

Exhibit 104 - The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.

______________________________________

* The information furnished under Item 2.02 and Item 9.01 of this Current Report on Form 8-K, including the exhibits, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange act of 1934, as amended, or otherwise subject to liabilities under that section, nor shall it be deemed incorporated by reference in any registration statement or other filings of the Company under the Securities act of 1933, as amended, except as shall be set forth by specific reference in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                          SUPERNUS PHARMACEUTICALS, INC.                                                         
  DATED: May 6, 2025      By:                                 /s/ Timothy Dec                                    
                                                              Timothy Dec                                        
                                                              Senior Vice-President and Chief Financial Officer